We serve Chemical Name:2-(6-methyl-3-nitropyridin-2-yl)acetonitrile CAS:131084-59-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(6-methyl-3-nitropyridin-2-yl)acetonitrile
CAS.NO:131084-59-8
Synonyms:2-(6-methyl-3-nitropyridin-2-yl)acetonitrile
Molecular Formula:C8H7N3O2
Molecular Weight:177.16000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:82.50000
Exact Mass:177.05400
LogP:1.88748
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(6-methyl-3-nitropyridin-2-yl)acetonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(6-methyl-3-nitropyridin-2-yl)acetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(6-methyl-3-nitropyridin-2-yl)acetonitrile Use and application,2-(6-methyl-3-nitropyridin-2-yl)acetonitrile technical grade,usp/ep/jp grade.
Related News: Biocatalytic processing offers many advantages over using conventional metal catalysts. The superior enantio- and regioselectivity of enzymes results in higher yields of purer product—typically comprising just a single enantiomer that has been modified on only a specific site. bismuth,lead manufacturers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. 2-Azabicyclo[3.3.1]nonan-6-one, 4-methylene-2-[(1R)-1-phenylethyl]- suppliers Joan Merrill, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, said: “Arthritis and rash are the most common and persistent problems in lupus and often have a significant impact on a person’s life. The strength of the data from this analysis is that anifrolumab was found to be consistently effective using three different ways of looking at rash and three different approaches to arthritis. gallane,molybdenum vendor & factory.
